|
1
|
Miner JH: Glomerular basement membrane
composition and the filtration barrier. Pediatr Nephrol.
26:1413–1417. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Levidiotis V and Power DA: New insights
into the molecular biology of the glomerular filtration barrier and
associated disease. Nephrology (Carlton). 10:157–166. 2005.
View Article : Google Scholar
|
|
3
|
Obeidat M and Ballermann BJ: Glomerular
endothelium: a porous sieve and formidable barrier. Exp Cell Res.
318:964–972. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Haraldsson BS: The endothelium as part of
the integrative glomerular barrier complex. Kidney Int. 85:8–11.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Haraldsson B, Nystrom J and Deen WM:
Properties of the glomerular barrier and mechanisms of proteinuria.
Physiol Rev. 88:451–487. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Savage CO: The biology of the glomerulus:
endothelial cells. Kidney Int. 45:314–319. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stylianou E and Saklatvala J:
Interleukin-1. Int J Biochem Cell Biol. 30:1075–1079. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Al-Sadi R, Boivin M and Ma T: Mechanism of
cytokine modulation of epithelial tight junction barrier. Front
Biosci (Landmark Ed). 14:2765–2778. 2009. View Article : Google Scholar
|
|
9
|
Yamanaka N and Shimizu A: Role of
glomerular endothelial damage in progressive renal disease. Kidney
Blood Press Res. 22:13–20. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee LK, Meyer TW, Pollock AS and Lovett
DH: Endothelial cell injury initiates glomerular sclerosis in the
rat remnant kidney. J Clin Invest. 96:953–964. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
van de Veerdonk FL and Netea MG: New
Insights in the Immunobiology of IL-1 Family Members. Front
Immunol. 4:1672013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao R, Zhou H and Su SB: A critical role
for interleukin-1beta in the progression of autoimmune diseases.
Int Immunopharmacol. 17:658–669. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Himmelfarb J, Le P, Klenzak J, Freedman S,
McMenamin ME and Ikizler TA: Impaired monocyte cytokine production
in critically ill patients with acute renal failure. Kidney Int.
66:2354–2360. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boraschi D, Bossu P, Macchia G, Ruggiero P
and Tagliabue A: Structure-function relationship in the IL-1
family. Front Biosci. 1:d270–d308. 1996.PubMed/NCBI
|
|
15
|
Auron PE: The interleukin 1 receptor:
ligand interactions and signal transduction. Cytokine Growth Factor
Rev. 9:221–237. 1998. View Article : Google Scholar
|
|
16
|
Dinarello CA: The IL-1 family and
inflammatory diseases. Clin Exp Rheumatol. 20:S1–S13. 2002.
|
|
17
|
Voronov E, Carmi Y and Apte RN: Role of
IL-1-mediated inflammation in tumor angiogenesis. Adv Exp Med Biol.
601:265–270. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wong D, Dorovini-Zis K and Vincent SR:
Cytokines, nitric oxide and cGMP modulate the permeability of an in
vitro model of the human blood-brain barrier. Exp Neurol.
190:446–455. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nooteboom A, Van Der Linden CJ and
Hendriks T: Tumor necrosis factor-alpha and interleukin-1beta
mediate endothelial permeability induced by
lipopolysaccharide-stimulated whole blood. Crit Care Med.
30:2063–2068. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ganter MT, Roux J, Miyazawa B, et al:
Interleukin-1beta causes acute lung injury via alphavbeta5 and
alphavbeta6 integrin-dependent mechanisms. Circ Res. 102:804–812.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Du P, Fan B, Han H, et al: NOD2 promotes
renal injury by exacerbating inflammation and podocyte insulin
resistance in diabetic nephropathy. Kidney Int. 84:265–276. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu J, Yuan L, Molema G, et al: Vascular
bed-specific regulation of the von Willebrand factor promoter in
the heart and skeletal muscle. Blood. 117:342–351. 2011. View Article : Google Scholar :
|
|
23
|
Becker PM, Verin AD, Booth MA, Liu F,
Birukova A and Garcia JG: Differential regulation of diverse
physiological responses to VEGF in pulmonary endothelial cells. Am
J Physiol. 281:L1500–L1511. 2001.
|
|
24
|
Birukova AA, Birukov KG, Smurova K, et al:
Novel role of microtubules in thrombin-induced endothelial barrier
dysfunction. FASEB J. 18:1879–1890. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hordijk PL, Anthony E, Mul FP, Rientsma R,
Oomen LC and Roos D: Vascular-endothelial-cadherin modulates
endothelial monolayer permeability. J Cell Sci. 112(Pt 12):
1915–1923. 1999.PubMed/NCBI
|
|
26
|
Ponnuchamy B and Khalil RA: Cellular
mediators of renal vascular dysfunction in hypertension. Am J
Physiol Regul Integr Comp Physiol. 296:R1001–R1018. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dejana E and Giampietro C: Vascular
endothelial-cadherin and vascular stability. Curr Opinion Hematol.
19:218–223. 2012. View Article : Google Scholar
|
|
28
|
Deen WM: What determines glomerular
capillary permeability? J Clin Invest. 114:1412–1414. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Obeidat M, Obeidat M and Ballermann BJ:
Glomerular endothelium: a porous sieve and formidable barrier. Exp
Cell Res. 318:964–972. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vestweber D: VE-cadherin: the major
endothelial adhesion molecule controlling cellular junctions and
blood vessel formation. Arterioscler Thromb Vasc Biol. 28:223–232.
2008. View Article : Google Scholar
|
|
31
|
Burke-Gaffney A and Keenan AK: Modulation
of human endothelial cell permeability by combinations of the
cytokines interleukin-1 alpha/beta, tumor necrosis factor-alpha and
interferon-gamma. Immunopharmacology. 25:1–9. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cromer WE, Zawieja SD, Tharakan B, Childs
EW, Newell MK and Zawieja DC: The effects of inflammatory cytokines
on lymphatic endothelial barrier function. Angiogenesi. 2013.
|
|
33
|
Qin W, Lu W, Li H, et al: Melatonin
inhibits IL1beta-induced MMP9 expression and activity in human
umbilical vein endothelial cells by suppressing NF-kappaB
activation. J Endocrinol. 214:145–153. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rigor RR, Beard RS Jr, Litovka OP and Yuan
SY: Interleukin-1beta-induced barrier dysfunction is signaled
through PKC-theta in human brain microvascular endothelium. Am J
Physiol Cell Physiol. 302:C1513–C1522. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Duffy HS, John GR, Lee SC, Brosnan CF and
Spray DC: Reciprocal regulation of the junctional proteins
claudin-1 and connexin43 by interleukin-1beta in primary human
fetal astrocytes. J Neurosci. 20:RC1142000.PubMed/NCBI
|
|
36
|
Qi J, Chi L, Bynum D and Banes AJ: Gap
junctions in IL-1beta-mediated cell survival response to strain. J
Appl Physiol. 110:1425–1431. 2011. View Article : Google Scholar
|
|
37
|
Kinjo T, Takashi M, Miyake K and Nagura H:
Phenotypic heterogeneity of vascular endothelial cells in the human
kidney. Cell Tissue Res. 256:27–34. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Atkins GB, Jain MK and Hamik A:
Endothelial differentiation: molecular mechanisms of specification
and heterogeneity. Arterioscler Thromb Vasc Biol. 31:1476–1484.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Aird WC: Mechanisms of endothelial cell
heterogeneity in health and disease. Circ Res. 98:159–162. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Deng DX, Tsalenko A, Vailaya A, et al:
Differences in vascular bed disease susceptibility reflect
differences in gene expression response to atherogenic stimuli. Cir
Res. 98:200–208. 2006. View Article : Google Scholar
|
|
41
|
Molema G and Aird WC: Vascular
heterogeneity in the kidney. Semin Nephrol. 32:145–155. 2012.
View Article : Google Scholar : PubMed/NCBI
|
